American Red Cross Cell and Gene Therapy Solutions

The American Red Cross provides allogeneic and autologous products and services for cell and gene therapy solutions: CAR-T collection, processing, storage and thawing within five MSAT labs. Our national network of mobilized apheresis collection sites, under one operating procedure, can efficiently reach more patients. In addition, our RUO/GMP allogenic starting materials support early development through commercialization. Reliable sourcing of quality starting cellular components is paramount to success. We provide access to a large pool of recallable donors, allowing for customization and scalability.